Bemnifosbuvir (hemisulfate), CAS [[2241337-84-6]]

Produktübersicht

• Artikelname: Bemnifosbuvir (hemisulfate), CAS [[2241337-84-6]]
• Artikelnummer: MCE-HY-137958
• Hersteller Artikelnummer: HY-137958
• Alternativnummer: MCE-HY-137958-10MG,MCE-HY-137958-100MG,MCE-HY-137958-25MG,MCE-HY-137958-5MG,MCE-HY-137958-10MMX1ML,MCE-HY-137958-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: AT-527

Produktbeschreibung

Bemnifosbuvir hemisulfate (AT-527), a hemisulfate salt of AT-511, a guanosine nucleotide proagent, is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir hemisulfate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC90=0.47 µM). Bemnifosbuvir hemisulfate has pangenotypic antiviral activity[1][2][3].

Produkteigenschaften

• Molekulargewicht: 630.58
• Reinheit: 99.38
• CAS Nummer: [2241337-84-6]
• Formel: C24H33FN7O7P.1/2H2O4S
• Target-Kategorie: HCV,SARS-CoV

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound